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BASIC FffiROBIAST GROWTH FACTOR AND HEPATOCYTE
GROWTH FACTOR CONTENT OF WOUND, REPAIR,
AND MUSCLE REGENERATION FLUIDS
RAYMOND

E. SICARD AND WENDY A. MAND

Regeneration and Organogenesis Section
Center for Wound Healing and Reparative Medicine
University of Minnesota
ABSTRACT

Injury produces marked changes to the local environment. Changes in both diversity and availability of bioactive substances at wound sites might discriminate
between repair and regeneration microenvironments and selectively drive events leading to final resolution. Among factors with potential relevance to wound
repair and regeneration are basi c fibroblast growth factor (bFGF) and hepatocyte growth factor (HGF). In this study, concentrations of these factors were
determined in fluids derived from wound, repair, and regeneration-conditioned models using enzyme-linked immunosorbent assays. All fluid s contained
substantial concentrations of bFGF which rose 5- to I 5-fold as resolution to injury was achieved. Mean bFGF content in regeneration fluid was three times
greater than in wound fluid (645.5 vs 224.2 pg/mL) early after injury (days I - 3). Maximal bFGF content of regeneration fluids did not differ from that of
wound fluids (3454.0 vs 3565 .5 pg/mL), but was achieved about 5 days earlier (i.e., 9 - II days rather than ;::: I 5 days postinjury). In contrast, HGF was not
consistently detected and was at much lower levels in wound, repair, or regeneration fluids . HGF content does not correlate either with repair or regeneration
or with time postinjury. Basic FGF appears to provide a convenient index of postinjury age but is a poor discriminator for wound repair and regeneration .

Injury triggers an adaptive series of systemic and local
changes that leads to correction of tissue damage. Two
contrasting modes of resolution are possi ble which differ
markedly in the quality, if not quantity, of tissue produced at sites
of injury. 1 Repair replaces damaged tissue with new connective
tissue whereas regeneration restores normal tissue integrity.
These processes rely on different effector cells, i.e., fibroblasts
for repair and parenchymal cells or their progenitors for
regeneration . In addition, it is reasonable to expect that
differences exist within the microenvironments of repair and
regeneration models that reflect, if not direct, the proliferation
and functional modulation of respective effector cells . Two major
classes of substances are known to be capable of playing these
roles: components of the extracellular matrix and growth factors
and cytokines. 2
The role of growth factors as determinants of repair and
regeneration is a major interest of this laboratory. Wound fluids
(WFs) stimulate proliferation of and collagen production by
fibroblasts in vitro. 3·4 In addition, WFs stimulate proliferation,
but not differentiation, of myoblasts.5 Mitogenic properties of
WFs are greatest early after injury (I - 5 days) and decrease later
(;::: 10 days postinjury) while collagen production is most strongly
promoted by late WFs. These properties reflect events associated
with wound repair. Sicard, et al.6 have reported that the in vivo
wound repair environment cannot support myotube formation .
These observations complement earlier in vitro studies5 and
suggest that the repair environment cannot support culmination of
regeneration . Thus, it appears that wound repair and regeneration
microenvironments have different intrinsic properties. However,
earlier studies failed to provide candidates for these properties.
Several growth factors have been identified which
participate in wound repair 2 and are potential modulators of
.skeletal muscle regeneration.7 Among the growth factors that

have been identified as important to wound healing are epidermal
growth factor (EGF), transforming growth factor (TGF)-a, TGFp, platelet-derived growth factor (PDGF), and several members
of the fibroblast growth factor (FGF) family. Skeletal muscle
regeneration is known to be influenced by insulin-like growth
factor I (IGF-1), TGF-P. and basic FGF (bFGF). In both instances,
bFGF is presumed to be a potent mitogen and TGF-P is believed
to play an important role in culmination of postinjury responses
either by promoting collagen deposition in wound repair or
inducing differentiation (or quiescence) in skeletal muscle
regeneration. In sharp contrast, hepatocyte growth factor (HGF)
has been identified as an agent capable of exerting selective
mitogenic influence at an injury site.8 HGF is present in
regenerating skeletal muscle 9 and is capable of mitogenically
stimulating myoblasts but not fibroblasts.s
Wound repair and skeletal muscle regeneration are processes
that are characterized by markedly different resolutions to injury
and depend on distinct effector cell types. The bioactive
substances that might regulate progression through each process
are similar but not identical between both systems . Ongoing
studies consider whether the presence or relative abundance of
growth factors in interstitial fluids might be of diagnosti c value.
Does the relative abundance of a particular growth factor in WFs
or regeneration fluid s (RFs) reflect or predict repair or
regeneration? Is the relative abundance of particular factors an
index of progression from one stage to another during postinjury
resolution? As an initial step, this study focused on one growth
factor common to both models, bFGF, and one expected to be
differentially restricted to the regeneration model , HGF. bFGF
and HGF content were measured by immunoassay in fluids
reflecting wound healing, skeletal muscle regeneration, and
fibrotic muscle repair (where regeneration was suppressed) .
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bFGF and HGF in Wound and Regeneration Fluids
MATERIALS AND METHODS

Animal model and interstitial fluid generation
Young male Fischer rats (F-344/SAS, 150- 175 g; Sasco,
Inc., Madison, WI) were used to generate interstitial fluids used
in this study: WF, RF, and muscle repair fluids (rFs). All samples
were derived from either a standard polyvinyl alcohol (PV A)
sponge wound healing model (for WFs) 5 or a PV A sponge model
adapted for skeletal muscle regeneration (for RFs and rFs)_lO
These latter sponges consisted of two types: the regeneration
model containing live minced muscle which subsequently
regenerate (yielding RFs) and a muscle repair model containing
minced muscle in which regeneration potential was suppressed by
thermally shocking muscle prior to implantation (for rFs).
Methods for sponge implantation and interstitial fluid
harvesting/recovery are described elsewhere.5 • 10 All procedures
involving animals were reviewed by the Animal Care and Use
Committee (University of Minnesota) and conform to guidelines
established by the National Research Council. 11
lmmunoassays
Assays for bFGF and HGF were conducted using
commercial enzyme-linked immunosorbent assay (ELISA) kits
purchased from R & D Systems (Minneapolis, MN). Standard
assays were conducted as outlined in protocols provided with
each kit. Color developed in ELISAs was measured using an EL
340 microtiter plate reader (Bio-Tek Instruments, Winooski, VT) .
Content of bFGF or HGF in samples was determined initially
using a KinetiCalc™ program (Bio-Tek Instruments, Winooski,
VT) then corrected for sample dilution. lnterassay variability was
between 5 and 8% (n = 11 replicate assays).
In addition, assays were modified to evaluate the potential
that heparin or heparin-containing molecules in fluids might
cause bFGF or HGF content to be underestimated. In these
assays, a second set of standards and of WFs, rFs, or RFs was
assayed with heparinase (heparinase III; E.C.C. 4.2.2.8) or
heperatinase (heparinase I; E.C.C. 4.2.2.7). Heparinases were
included at 250 mU/well (final concentration) during the first
incubation (2 hours at room temperature). Since HGF is secreted
as a latent factor that can be activated by tissue plasminogen
activator (tPA) and urokinase (uK; E.C.C. 3.4.21.73), HGF
content also was measured in ELISAs in which these enzymes
were added. tPA and uK were included at 30 U or 100 mU per
well, respectively, during the first incubation (as above). Adding
enzymes did not alter performance of the respective ELISAs. All
enzymes were purchased from Sigma Chemical Corp (St. Louis,
MO)
Statistical analyses of data were peformed using Stat View™
(BrainPower, Inc., Calabasas, CA). Analyses of composite effects
were performed by one-way analysis of variance. Subsequent
comparisons between groups were accomplished using unpaired t
tests. Data are given as means ± I standard error. Differences
were considered significant at p < 0.05; no further assignments of
significance were made.
RESULTS

A total of 87 fluids were analyzed. Twenty-nine were
assayed for both bFGF and HGF; while 36 were assayed for
bFGF only and 22 were assayed for HGF only.
Substantial bFGF was found in all fluids within the first
three days after injury (Table I). Mean bFGF content rose by 44%
to 68% in fluids associated with wound repair but decreased by
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50% in fluids conditioned by regenerating skeletal muscle toward
the end of the first week postinjury (Table 1). Content of bFGF
rose further during the next week, reaching peak concentrations
by the end of the second week postinjury (Table 1). No further
increase was noted over the ensuing two weeks. Maximal
increases in bFGF content were 14.3- and 17.4-fold for WFs and
rFs, respectively, but only 5.3-fold for RFs (Table 1). Peak bFGF
content in RFs was attained earlier than in WFs and rFs (Table I).
Variations (between 12% and 41% of sample means) in
bFGF content were noted (Table 1). This seems to represent
variation in intrinsic bFGF content of the samples and not
variability within the ELISA since variability among II replicate
assays ranged between 5 and 8% for bFGF concentrations over a
range of 60 to 2000 pg/mL.
Measurements of bFGF content were not compromised by
association with heparin-containing substances that might have
masked bFGF immunoreactivity. Assays of fluids for bFGF
content were conducted both in the absence and presence of
heparinases (I or III). A total of 16 WFs, 9 rFs, and 7 RFs were
evaluated in this manner. No differences in bFGF content were
found: concentrations of bFGF varied by 7.4 ± 1.0% between
samples assayed in the presence and absence of enzymes. This
variation is within the variability of the assay (5 - 8%).
Correlation coefficients for assays conducted in the absence of
heparinases with those performed in the presence of heparinases
ranged between 0.968 and 1.000 showing excellent concordance
between these assays.
Fifty-one of these same samples (20 WFs, I 0 rFs, and 21
RFs) were assayed for HGF content. All but seven had no
measureable HGF (Table 1). Fourteen samples were assayed in
the presence of heparinase with no change in outcome (data not
shown). In order to ascertain whether HGF was not detected
because it was present in its latent form, 23 samples were assayed
in the presence of uK (n = 22) or tPA (n = 13). In five of these
samples, HGF content was increased following exposure to
enzymes while in two instances content decreased. Regardless,
no statistical effect of enzme treatment was observed: 23.8 ± I 0.8
pg/mL without enzyme vs 42.7 ± 13.8 pg/mL with enzyme.
DISCUSSION

Wound repair and regeneration yield contrasting resolutions
to tissue injury. 1 Wound repair replaces damaged tissues with
connective tissue deposited by fibroblasts. This creates a new
stroma-to-cell ratio in the tissue and potentially compromises
functional integrity. In contrast, regeneration makes use of
parenchymal cells (or their precursors) to restore tissue integrity.
This apparent reliance on different effector cells for alternate
resolutions to injury creates an expectation that distinct
regulatory agents are used for repair and regeneration or that
particular regulatory substances are used differentially in each
process. Components of the extracellular matrix and polypeptide
growth factors and cytokines are excellent candidates for such
roles. 2
The present study considered two specific candidates: bFGF
and HGF. Previous studies have shown that bFGF is present in
relevant tissues 12 - 14 and is capable of promoting both wound
repair lS, !6 and skeletal muscle regeneration. 12 · 14· 17 While both
fibroblasts and myoblasts (satellite cells) are resident in skeletal
muscle, following muscle injury there is preferential myogenesis
over fibrosis to achieve regeneration. Might this be driven, at
least in part, by changes in bFGF content or bioactivity in

journal of the Minnesota Academy of Science

bFGF and HGF in Wound and Regeneration Fluids

Table 1: Concentrations of basic fibroblast growth factor and hepatocyte growth factor in wound, repair, and skeletal
muscle regeneration fluids
AGE:

15 days

1 - 3 days

5 & 7 days

9- 11 days

224.2 ± 53 .8
(12)
204.7 ± 55 .8
(6)
645 .5 ± l3l.Ot
(7)

376.4 ± 155.6
(4)
294.7 ± 54.6
(4)
324.1 ± 72.0
(5)

2256.4 ± 280.6*
(4)
2073.7 ± 57 1.2*
(3 )
3454.0 ± 596. 8*
(3)

3199.3 ± 522.9*
(9)
3565.5 ± 497. 3*
(3)
3126. 1 ± 723.0*
(5)

32.4 ± 22.7
(8)
[34 ± 17; (3)]2

14.0 ± 14.0 1
(4)

ND

ND

(2)

(6)

ND

ND

ND

(3)

(3)
[17.5 ± 17.5; (2)]
25 .2 ± 19.6
(6)
[27 ± 27; (3)]

5o.o ± 5o.o 1
(3)
120.0 ± 120.0 1
(4)
[95; (1)]

ND

;?:

bFGF (pglmL)

WF
rF
RF
H GF (pglmL)

WF

rF

RF

ND
(8)

( 1)

(3)

Data are means ± 1 standard error of the mean; sample size (number of fluids assayed) is given in parantheses
WF =wound fluid; rF =repair fluid (contains nonregenerating muscle); RF =regeneration fluid; ND =not detectable
* = p < 0.05 vs day 1 - 3 and vs day 5 & 7; t = p < 0.05 vs WF and rF
1 HGF detected in single sample only
2 values in brackets were determined with urokinase or tissue plasminogen activator in the assays
regenerating skeletal muscle that differs from that encountered in
healing wounds? It has been known for a decade that some
bioactive property is released following crush injury to muscle
that is mitogenic for myoblasts but not fibroblasts. 18 Recently,
HGF has been implicated as that mitogen. 8 Might HGF be a
selection factor that promotes muscle regeneration (i.e., myoblast
activation and expansion) over fibrosis (i.e., fibroblast activation
and expansion)?
Affirmative answers to the questions posed above would
predict a different pattern of change in bFGF content in fluids
from regenerating muscle than from wound repair models, on the
one hand, and measurable levels of HGF in fluids from
regenerating muscle but not from tissues undergoing repair, on
the other. The results of this study (Table 1) do not fulfi ll either
prediction.
The possibility that injured skeletal muscle releases HGF as
a factor to selectively favor muscle regenerati on has intriguing
implications. However, the results of this study do not su pport
such a role for HGF. HGF generally was not detectable in
interstitial fluids associated either with wound repai r or muscle
regenerati on. Furthermore, in those few instances where HGF
was measured, it was not restricted to tissues containing muscle
(Table 1). These data would suggest that soluble HGF is likely
not a gate-keeper for initiation of regeneration over repair.
However, the design of this study cannot exclude the possibility
that HGF has a limited functional range. Specifically, HGF might
bind to local muscle matrix and not be released as a soluble
factor. In fact, localization of HGF in regenerating skeletal
muscle 9 suggests that this is highly probable. Other studies are
required to explore this question further.

Special Issue: Vol. 63, No.2, 1998

All fluid samples studied contained appreciable
concentrations of bFGF. Except for the first three days after
injury, no significant differences in bFGF were observed among
the three models (Table 1). It appears that the relative availability
of bFGF in tissue undergoing repair or in regenerating skeletal
muscle is similar. This suggests that bFGF is not a selective
regulator of regeneration over repair. However, this study cannot
determine what proportion of bFGF is restricted to local matrix
and, therefore, is not available for diffusion as a soluble factor.
Different degrees ofbFGF immobilization by extracellular matrix
between these models remains a possibility. Moreover, it is
possible that the threefold greater concentration of bFGF in RFs
during the firs t three days after injury (Table I) favors expansion
of the satellite cell pool to an extent sufficient to meet the
subsequent needs of regeneration. These are issues that merit
further attention.
While soluble bFGF content does not discriminate between
repair and regeneration, it might provide an index of relative
repair or regeneration age. We noted that bFGF content was lower
during the fi rst week after injury than thereafter (Table 1).
However, this pattern is somewhat enigmati c since early WFs are
substantially more mitogenic for both myoblasts and fibroblasts
than are late WFs.3-S In addition , cocktails containing bFGF at
concentrations measured in these fluids failed to match the
mitogenic properties of the fluids they were intended to mimic. 19
However, these experiments do not address the question of how
interactions between bFGF and other factors might modify its
mitogenic potential in these fluids. Nevertheless, these
observations suggest that bFGF is not itself a major mitogen in
these fluids, whether associated with repair or regeneration.
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In summary, this investigation revealed that bFGF, but not
HGF, is present as a soluble factor in interstitial fluids associated
with wound repair and with skeletal muscle regeneration. In
addition, bFGF content is greater in later wound and regeneration
fluids than in earlier ones but generally does not differ between
wound
repair
and
skeletal
muscle
regeneration
microenvironments. Differential roles for soluble HGF and bFGF
as determinants of repair or regeneration are not supported by the
results of this study. Future studies will explore interactions of
bFGF and HGF with other growth factors and cytokines or with
components of extracellular matrix as determinants of possible
differential roles of these growth factors in repair and
regeneration.
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